Literature DB >> 18812958

Delayed visual deficits and monocular blindness after endovascular treatment of large and giant paraophthalmic aneurysms.

Raymond D Turner1, James V Byrne, Michael E Kelly, Aristotelis P Mitsos, Vivek Gonugunta, Shivu Lalloo, Peter A Rasmussen, David Fiorella.   

Abstract

OBJECTIVE: Paraophthalmic aneurysms may exert mass effect on the optic apparatus. Although surgical clipping and endovascular coiling of these aneurysms can be complicated by immediate postoperative visual deterioration, endovascular coil embolization has the unique risk of visual complications later (>24 h) in the perioperative period.
METHODS: Six patients with a delayed onset of vision loss after technically successful coil embolization of paraophthalmic region aneurysms were identified. All available clinical, angiographic, and cross sectional imaging for these patients, in addition to histopathological data, were reviewed.
RESULTS: Six patients who underwent endovascular treatment of paraclinoid aneurysms at our institutions developed delayed postoperative visual decline. Four were treated with combination hydrogel-coated and bare platinum coils, one with hydrogel-coated coils, and one with bare platinum coils. Three patients presented with some degree of visual impairment caused by their aneurysms. Catheter angiography performed after the visual decline revealed no etiology in any of the cases. Magnetic resonance imaging was performed in all patients and was unremarkable in two. At follow-up, two had improved, three remained unchanged, and one patient died before any follow-up assessment of her vision.
CONCLUSION: Both acute and delayed visual disturbances can present after the endovascular treatment of carotid artery paraophthalmic aneurysms. Delayed visual deterioration can be observed up to 35 days after embolization. Although the cause is still undefined, it is likely that the more delayed visual deterioration can be attributed to progression of mass effect and/or perianeurysmal inflammatory change. Our case series raises the possibility that this phenomenon may be more likely with HydroCoil (HydroCoil Embolic System; MicroVention, Aliso Viejo, CA). This possibility should be taken into account by neurointerventionists when selecting a coil type to treat large paraophthalmic aneurysms.

Entities:  

Mesh:

Year:  2008        PMID: 18812958     DOI: 10.1227/01.NEU.0000324730.37144.4B

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  18 in total

1.  Hydrogel versus Bare Platinum Coils in Patients with Large or Recurrent Aneurysms Prone to Recurrence after Endovascular Treatment: A Randomized Controlled Trial.

Authors:  J Raymond; R Klink; M Chagnon; S L Barnwell; A J Evans; J Mocco; B H Hoh; A S Turk; R D Turner; H Desal; D Fiorella; S Bracard; A Weill; F Guilbert; S Lanthier; A J Fox; T E Darsaut; P M White; D Roy
Journal:  AJNR Am J Neuroradiol       Date:  2017-01-12       Impact factor: 3.825

2.  Postoperative ophthalmic artery pseudoaneurysm presenting as monocular blindness: successful endovascular treatment.

Authors:  Sandro Rossitti; Renata Radzinska; Patrick Vigren; Jan Hillman
Journal:  Klin Neuroradiol       Date:  2009-06-19

3.  "Successful" coiling of a giant ophthalmic aneurysm resulting in blindness: case report and critical review.

Authors:  Ramsey Ashour; Jeremiah Johnson; Koji Ebersole; Mohammad Ali Aziz-Sultan
Journal:  Neurosurg Rev       Date:  2013-05-01       Impact factor: 3.042

4.  Return of visual function after bilateral visual loss following flow diversion embolization of a giant ophthalmic aneurysm due to both reduction in mass effect and reduction in aneurysm pulsation.

Authors:  Saharsh Patel; Kyle M Fargen; Keith Peters; Peter Krall; Hazem Samy; Brian L Hoh
Journal:  BMJ Case Rep       Date:  2014-01-10

5.  Vision outcomes and major complications after endovascular coil embolization of ophthalmic segment aneurysms.

Authors:  C R Durst; R M Starke; J Gaughen; Q Nguyen; J Patrie; M E Jensen; A J Evans
Journal:  AJNR Am J Neuroradiol       Date:  2014-07-03       Impact factor: 3.825

6.  Optic pathway infarct after Onyx HD 500 aneurysm embolization: visual pathway ischemia from superior hypophyseal artery occlusion.

Authors:  Jeremiah Nicholas Johnson; Mohamed Elhammady; Judith Post; Joshua Pasol; Koji Ebersole; Mohammad Ali Aziz-Sultan
Journal:  BMJ Case Rep       Date:  2013-12-17

7.  Patients prone to recurrence after endovascular treatment: periprocedural results of the PRET randomized trial on large and recurrent aneurysms.

Authors:  J Raymond; R Klink; M Chagnon; S L Barnwell; A J Evans; J Mocco; B L Hoh; A S Turk; R D Turner; H Desal; D Fiorella; S Bracard; A Weill; F Guilbert; D Roy
Journal:  AJNR Am J Neuroradiol       Date:  2014-06-19       Impact factor: 3.825

8.  The extradural minipterional approach for the treatment of paraclinoid aneurysms: a cadaver stepwise dissection and clinical case series.

Authors:  Rafael Martinez-Perez; Holger Joswig; Asterios Tsimpas; Tomas Poblete; Pablo Albiña; Ivan Perales; Jorge M Mura
Journal:  Neurosurg Rev       Date:  2019-12-09       Impact factor: 3.042

9.  Anterior Optic Pathway Compression Due to Internal Carotid Artery Aneurysms: Neurosurgical Management and Outcomes.

Authors:  Wonhyoung Park; Jung Cheol Park; Kyunghwa Han; Jae Sung Ahn; Byung Duk Kwun
Journal:  J Stroke       Date:  2015-09-30       Impact factor: 6.967

10.  Extended endoscopic endonasal approaches for cerebral aneurysms: anatomical, virtual reality and morphometric study.

Authors:  Alberto Di Somma; Matteo de Notaris; Vita Stagno; Luis Serra; Joaquim Enseñat; Isam Alobid; Joan San Molina; Joan Berenguer; Paolo Cappabianca; Alberto Prats-Galino
Journal:  Biomed Res Int       Date:  2014-01-19       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.